ALDH+ Cancer Precursor Cells in Drug Response Prediction
.
Mr. Ed Field, Chief Operating Officer at Aldagen, explains the principles behind ALDEFLUOR™-based detection of ALDH bright cells and discusses evidence demonstrating ALDH’s potential as a biomarker for cancer stem cell characterization and tumor prognosis.
Publish Date:
June 25, 2015
Related Multimedia
-
How to Detect and Isolate Normal and Cancer Stem Cells Based on ALDH Activity with ALDEFLUOR™
Publish Date: September 09, 2009 -
Flow Cytometry Analysis of ALDH Bright Cells with the ALDEFLUOR™ Assay Kit
Publish Date: September 06, 2011 -
Potential Applications of ALDH Bright Cells In Regenerative Medicine
Publish Date: May 27, 2011
Explore Our Products
-
For the identification, evaluation and isolation of stem and progenitor cells expressing high levels of ALDH
